These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22843169)

  • 61. Transient pseudothrombocytopenia associated with immune heparin-induced thrombocytopenia complicated by pulmonary embolism.
    Zimrin AB; Warkentin TE
    Thromb Haemost; 2013 May; 109(5):971-3. PubMed ID: 23636478
    [No Abstract]   [Full Text] [Related]  

  • 62. Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia.
    Tutwiler V; Madeeva D; Ahn HS; Andrianova I; Hayes V; Zheng XL; Cines DB; McKenzie SE; Poncz M; Rauova L
    Blood; 2016 Jan; 127(4):464-72. PubMed ID: 26518435
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Anti-heparin/platelet factor 4 antibodies and heparin-induced thrombocytopenia--review].
    Lei Q; Chen L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):457-60. PubMed ID: 18426686
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Functional characterization of antibodies against heparin-platelet factor 4 complex in heparin-induced thrombocytopenia patients in Asian-Indians: relevance to inflammatory markers.
    Kannan M; Ahmad S; Ahmad F; Kale S; Hoppensteadt DA; Fareed J; Saxena R
    Blood Coagul Fibrinolysis; 2005 Oct; 16(7):487-90. PubMed ID: 16175007
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis.
    Greinacher A; Warkentin TE
    Expert Rev Hematol; 2008 Oct; 1(1):75-85. PubMed ID: 21083008
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differential prevalence of anti-heparin-PF4 immunoglobulin subtypes in patients treated with clivarin and heparin: implications in the HIT pathogenesis.
    Ahmad S; Untch B; Haas S; Hoppensteadt DA; Misselwitz F; Messmore HL; Walenga JM; Fareed J
    Mol Cell Biochem; 2004 Mar; 258(1-2):163-70. PubMed ID: 15030181
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
    Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
    Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
    [TBL] [Abstract][Full Text] [Related]  

  • 68. When heparin causes thrombosis: significance, recognition, and management of heparin-induced thrombocytopenia in dialysis patients.
    Chang JJ; Parikh CR
    Semin Dial; 2006; 19(4):297-304. PubMed ID: 16893407
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The identification and management of heparin-induced thrombocytopenia in the vascular patient.
    LaMuraglia GM; Houbballah R; Laposata M
    J Vasc Surg; 2012 Feb; 55(2):562-70. PubMed ID: 22188737
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bivalirudin anticoagulation for a patient with hypercoagulable immune syndromes undergoing mitral valve surgery.
    Cain RL; Spiess BD; Nelson M; Deanda A; McCarthy HL; Green JA
    Ann Thorac Surg; 2006 Jun; 81(6):2308-10. PubMed ID: 16731183
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rapid and accurate Bayesian diagnosis of heparin-induced thrombocytopenia.
    Marchetti M; Barelli S; Zermatten MG; Monnin-Respen F; Matthey-Guirao E; Nicolas N; Gomez F; Goodyer M; Gerschheimer C; Alberio L
    Blood; 2020 Apr; 135(14):1171-1184. PubMed ID: 31945147
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Heparin-induced thrombocytopenia in hemodialysis patients.
    Yamamoto S; Koide M; Matsuo M; Suzuki S; Ohtaka M; Saika S; Matsuo T
    Am J Kidney Dis; 1996 Jul; 28(1):82-5. PubMed ID: 8712226
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Heparin-induced thrombocytopenia: a practical review.
    Hong MS; Amanullah AM
    Rev Cardiovasc Med; 2010; 11(1):13-25. PubMed ID: 20495512
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Serotonin release assay (SRA)-negative HIT, a newly recognized entity: Implications for diagnosis and management.
    Pandya KA; Johnson EG; Davis GA; Padmanabhan A
    Thromb Res; 2018 Dec; 172():169-171. PubMed ID: 30419472
    [No Abstract]   [Full Text] [Related]  

  • 75. The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy.
    Hassell K
    Chest; 2005 Feb; 127(2 Suppl):1S-8S. PubMed ID: 15706025
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical presentation, temporal relationship, and outcome in thirty-three patients with type 2 heparin-induced thrombocytopenia after cardiotomy.
    Wan C; Warner M; De Varennes B; Ergina P; Cecere R; Lachapelle K
    Ann Thorac Surg; 2006 Jul; 82(1):21-6. PubMed ID: 16798180
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Perioperative thrombocytopenia in cardiac surgical patients - incidence of heparin-induced thrombocytopenia, morbidities and mortality.
    Thielmann M; Bunschkowski M; Tossios P; Selleng S; Marggraf G; Greinacher A; Jakob H; Massoudy P
    Eur J Cardiothorac Surg; 2010 Jun; 37(6):1391-5. PubMed ID: 20138779
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Heparin-induced thrombocytopenia.
    Warkentin TE
    Hematol Oncol Clin North Am; 2007 Aug; 21(4):589-607, v. PubMed ID: 17666280
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Delayed-onset heparin-induced thrombocytopenia and cerebral thrombosis after a single administration of unfractionated heparin.
    Warkentin TE; Bernstein RA
    N Engl J Med; 2003 Mar; 348(11):1067-9. PubMed ID: 12637624
    [No Abstract]   [Full Text] [Related]  

  • 80. Treatment of heparin-induced thrombocytopenia.
    Greinacher A
    Thromb Haemost; 1999 Aug; 82(2):457-67. PubMed ID: 10605737
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.